Aggregated
No track record data- Bullish
- 6
- Hold
- 2
- Bearish
- 1
Needham
A Needham analyst with 192 tracked ratings across 44 distinct tickers has a 4.6 out of 5 stars track record and a 46.4% success rate on the captured sample.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| RNAC | 2026-05-26 | buy | $40.00 | Aggregated |
| CELC | 2026-05-15 | buy | $157.00 | Aggregated |
| FATE | 2026-05-13 | hold | - | Aggregated |
| NKTX | 2026-05-13 | buy | $11.00 | Aggregated |
| ARTV | 2026-05-12 | buy | $41.00 | Aggregated |
| ABSI | 2026-05-08 | buy | $7.00 | Aggregated |
| LYEL | 2026-05-07 | buy | $44.00 | Aggregated |
| RXRX | 2026-05-07 | buy | $8.00 | Aggregated |
| SRPT | 2026-05-07 | sell | - | Aggregated |
| IMCR | 2026-05-06 | buy | $75.00 | Aggregated |
| TSHA | 2026-05-06 | buy | $12.00 | Aggregated |
| CRSP | 2026-05-05 | buy | $82.00 | Aggregated |
| ARTV | 2026-05-04 | buy | $18.00 | Aggregated |
| CELC | 2026-05-04 | buy | $157.00 | Aggregated |
| RNAC | 2026-04-30 | buy | $42.00 | Aggregated |
| NRIX | 2026-04-23 | buy | $26.00 | Aggregated |
| LYEL | 2026-04-10 | buy | $44.00 | Aggregated |
| AUTL | 2026-04-09 | buy | $10.00 | Aggregated |
| NRIX | 2026-04-08 | buy | $26.00 | Aggregated |
| ABSI | 2026-03-30 | buy | $7.00 | Aggregated |
| CELC | 2026-03-26 | buy | $122.00 | Aggregated |
| NKTX | 2026-03-26 | buy | $11.00 | Aggregated |
| SRPT | 2026-03-26 | sell | - | Aggregated |
| ABSI | 2026-03-25 | buy | $7.00 | Aggregated |
| SLDB | 2026-03-20 | buy | $19.00 | Aggregated |
| TSHA | 2026-03-19 | buy | $12.00 | Aggregated |
| ABSI | 2026-03-18 | buy | $7.00 | Aggregated |
| CELC | 2026-03-17 | buy | $122.00 | Aggregated |
| ARTV | 2026-03-11 | buy | $18.00 | Aggregated |
| CELC | 2026-03-10 | buy | $122.00 | Aggregated |
| RNAC | 2026-03-09 | buy | $42.00 | Aggregated |
| TSHA | 2026-03-03 | buy | $10.00 | Aggregated |
| IMCR | 2026-02-26 | buy | $75.00 | Aggregated |
| RXRX | 2026-02-26 | buy | $8.00 | Aggregated |
| ACLX | 2026-02-23 | hold | - | Aggregated |
| CRSP | 2026-02-13 | buy | $82.00 | Aggregated |
| ACLX | 2026-02-05 | buy | $105.00 | Aggregated |
| NRIX | 2026-01-29 | buy | $26.00 | Aggregated |
| MREO | 2026-01-13 | buy | $3.00 | Aggregated |
| RNAC | 2026-01-09 | buy | $42.00 | Aggregated |
| CRSP | 2025-12-23 | buy | $80.00 | Aggregated |
| MREO | 2025-12-22 | buy | $5.00 | Aggregated |
| ABSI | 2025-12-12 | buy | $7.00 | Aggregated |
| ACLX | 2025-12-08 | buy | $105.00 | Aggregated |
| NRIX | 2025-12-08 | buy | $26.00 | Aggregated |
| ABSI | 2025-11-13 | buy | $7.00 | Aggregated |
| ABSIABSCI CORP | 2025-11-13 | unknown | $7.00 | Aggregated |
| CRSP | 2025-11-10 | buy | $80.00 | Aggregated |
| GERN | 2025-11-05 | buy | $4.00 | Aggregated |
| GERNGERON CORP. | 2025-11-05 | unknown | $4.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| RNAC | 14 | 2026-05-26 | Aggregated |
| CELC | 12 | 2026-05-15 | Aggregated |
| FATE | 10 | 2026-05-13 | Aggregated |
| NKTX | 12 | 2026-05-13 | Aggregated |
| ARTV | 11 | 2026-05-12 | Aggregated |
| ABSI | 13 | 2026-05-08 | Aggregated |
| LYEL | 2 | 2026-05-07 | Aggregated |
| RXRX | 16 | 2026-05-07 | Aggregated |
| SRPT | 2 | 2026-05-07 | Aggregated |
| IMCR | 7 | 2026-05-06 | Aggregated |
| TSHA | 11 | 2026-05-06 | Aggregated |
| CRSP | 7 | 2026-05-05 | Aggregated |
| NRIX | 7 | 2026-04-23 | Aggregated |
| AUTL | 1 | 2026-04-09 | Aggregated |
| SLDB | 1 | 2026-03-20 | Aggregated |
| ACLX | 5 | 2026-02-23 | Aggregated |
| MREO | 11 | 2026-01-13 | Aggregated |
| ABSIABSCI CORP | 1 | 2025-11-13 | Aggregated |
| GERN | 10 | 2025-11-05 | Aggregated |
| GERNGERON CORP. | 1 | 2025-11-05 | Aggregated |
| NRIXNURIX THERAPEUTICS INC | 1 | 2025-11-04 | Aggregated |
| TCRXTSCAN THERAPEUTICS INC | 1 | 2025-11-04 | Aggregated |
| AUTLAUTOLUS THERAPEUTICS PLC - ADR | 1 | 2025-10-20 | Aggregated |
| CELCCELCUITY INC | 1 | 2025-10-20 | Aggregated |
| TSHATAYSHA GENE THERAPIES INC | 1 | 2025-10-02 | Aggregated |
| FOLDAMICUS THERAPEUTICS INC | 1 | 2025-09-18 | Aggregated |
| RXRXRECURSION PHARMACEUTICALS INC - ORDINARY SHARES - CLASS A | 1 | 2025-09-11 | Aggregated |
| IMABI-MAB - ADR | 1 | 2025-08-20 | Aggregated |
| GBIOGENERATION BIO CO | 1 | 2025-08-13 | Aggregated |
| NKTXNKARTA INC | 1 | 2025-08-13 | Aggregated |
| RCKT | 2 | 2025-07-24 | Aggregated |
| CRSPCRISPR THERAPEUTICS AG | 1 | 2025-07-08 | Aggregated |
| SRPTSAREPTA THERAPEUTICS INC | 1 | 2025-06-16 | Aggregated |
| RCKTROCKET PHARMACEUTICALS INC | 1 | 2025-05-27 | Aggregated |
| MREOMEREO BIOPHARMA GROUP PLC - ADR | 1 | 2025-05-13 | Aggregated |
| IMCRIMMUNOCORE HOLDINGS PLC - ADR | 1 | 2025-04-10 | Aggregated |
| RNACCARTESIAN THERAPEUTICS INC | 1 | 2025-04-09 | Aggregated |
| ARTVARTIVA BIOTHERAPEUTICS INC | 1 | 2025-04-08 | Aggregated |
| STTK | 7 | 2025-03-27 | Aggregated |
| ACLXARCELLX INC | 1 | 2024-12-10 | Aggregated |
| STTKSHATTUCK LABS INC | 1 | 2024-10-02 | Aggregated |
| NXTC | 9 | 2024-08-02 | Aggregated |
| GTHXG1 THERAPEUTICS INC | 1 | 2024-06-25 | Aggregated |
| NXTCNEXTCURE INC | 1 | 2024-03-20 | Aggregated |